Concordia Healthcare confirms discussions about potential deal
Canadian pharmaceutical business Concordia Healthcare Corp (Nasdaq: CXRX, TSX: CXR) has formed a special committee of the board of directors to examine strategic alternatives potentially available to it. Concordia said it "has had discussions," but that a deal remains uncertain. The announcement followed media reports that Blackstone Group, a U.S. private equity firm, is considering an acquisition of the Oakville, Ont.-based company. European private equity firm Cinven has been a minority investor in Concordia since October 2015.
22 April 2016•3 mins read
